Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589320> ?p ?o ?g. }
- W2589320 endingPage "172" @default.
- W2589320 startingPage "166" @default.
- W2589320 abstract "Abstract Relatively nonmyelotoxic drugs and drug combinations were investigated for their ability to eliminate malignant cells from human bone marrow. In vitro 90% inhibitory concentration (IC90) doses were established on granulocyte macrophage colony-forming units (GM-CFU) in culture of bone marrow by using the GM-CFU assay for the following drugs: 4- hydroperoxycyclophosphamide (4-HC), Adriamycin, L-asparaginase, bleomycin, hydrocortisone, VP-16, spirogermanium, Taxol, and vincristine. The leukemic cell kill efficiency of these drugs at IC90 doses was compared with that of 4-HC on acute lymphoid leukemia (ALL) cell lines by using the limiting-dilution assay. Under these conditions, no single drug was superior to 4-HC. To increase the in vitro effect in leukemic cell kill, combinations of vincristine with hydrocortisone, Adriamycin, VP-16, and 4-HC were investigated. Vincristine at 1 to 5 micrograms/mL increased the marrow cytotoxicity of hydrocortisone, Adriamycin, and VP-16, but it was protective (subadditive) with 4-HC. Vincristine and 4-HC in combination was additive to supraadditive on ALL cell lines, increased the leukemic cell kill by one to two logs above 4-HC alone at IC90 doses (P less than .05), and was not affected by the addition of excess marrow cells. The recommended doses for chemopurging in clinical studies are vincristine, 1 to 5 micrograms/mL, plus 4-HC, 5 micrograms/mL." @default.
- W2589320 created "2016-06-24" @default.
- W2589320 creator A5005503184 @default.
- W2589320 creator A5012745694 @default.
- W2589320 creator A5014622052 @default.
- W2589320 creator A5017289995 @default.
- W2589320 creator A5021295987 @default.
- W2589320 creator A5052307588 @default.
- W2589320 creator A5052894313 @default.
- W2589320 creator A5066206647 @default.
- W2589320 creator A5066439603 @default.
- W2589320 creator A5067315975 @default.
- W2589320 date "1988-01-01" @default.
- W2589320 modified "2023-09-27" @default.
- W2589320 title "Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia" @default.
- W2589320 cites W1488826698 @default.
- W2589320 cites W1490499251 @default.
- W2589320 cites W1557517307 @default.
- W2589320 cites W1571107804 @default.
- W2589320 cites W1893863133 @default.
- W2589320 cites W1971629179 @default.
- W2589320 cites W2002287505 @default.
- W2589320 cites W2030407167 @default.
- W2589320 cites W2045096143 @default.
- W2589320 cites W2079571554 @default.
- W2589320 cites W2168885796 @default.
- W2589320 cites W2327274075 @default.
- W2589320 cites W2339392195 @default.
- W2589320 cites W2396968931 @default.
- W2589320 cites W2399832009 @default.
- W2589320 cites W2409856626 @default.
- W2589320 cites W2410594577 @default.
- W2589320 cites W2413041843 @default.
- W2589320 cites W2416793533 @default.
- W2589320 cites W2439865764 @default.
- W2589320 cites W2468590936 @default.
- W2589320 cites W284218086 @default.
- W2589320 cites W295837541 @default.
- W2589320 cites W317817448 @default.
- W2589320 cites W342440787 @default.
- W2589320 cites W58638097 @default.
- W2589320 cites W2007316273 @default.
- W2589320 cites W2461392678 @default.
- W2589320 doi "https://doi.org/10.1182/blood.v71.1.166.166" @default.
- W2589320 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2446678" @default.
- W2589320 hasPublicationYear "1988" @default.
- W2589320 type Work @default.
- W2589320 sameAs 2589320 @default.
- W2589320 citedByCount "19" @default.
- W2589320 crossrefType "journal-article" @default.
- W2589320 hasAuthorship W2589320A5005503184 @default.
- W2589320 hasAuthorship W2589320A5012745694 @default.
- W2589320 hasAuthorship W2589320A5014622052 @default.
- W2589320 hasAuthorship W2589320A5017289995 @default.
- W2589320 hasAuthorship W2589320A5021295987 @default.
- W2589320 hasAuthorship W2589320A5052307588 @default.
- W2589320 hasAuthorship W2589320A5052894313 @default.
- W2589320 hasAuthorship W2589320A5066206647 @default.
- W2589320 hasAuthorship W2589320A5066439603 @default.
- W2589320 hasAuthorship W2589320A5067315975 @default.
- W2589320 hasBestOaLocation W25893201 @default.
- W2589320 hasConcept C126322002 @default.
- W2589320 hasConcept C185592680 @default.
- W2589320 hasConcept C203014093 @default.
- W2589320 hasConcept C2776232574 @default.
- W2589320 hasConcept C2776694085 @default.
- W2589320 hasConcept C2776755627 @default.
- W2589320 hasConcept C2778461978 @default.
- W2589320 hasConcept C2779429289 @default.
- W2589320 hasConcept C2780007613 @default.
- W2589320 hasConcept C2781107101 @default.
- W2589320 hasConcept C2909962599 @default.
- W2589320 hasConcept C71924100 @default.
- W2589320 hasConcept C98274493 @default.
- W2589320 hasConceptScore W2589320C126322002 @default.
- W2589320 hasConceptScore W2589320C185592680 @default.
- W2589320 hasConceptScore W2589320C203014093 @default.
- W2589320 hasConceptScore W2589320C2776232574 @default.
- W2589320 hasConceptScore W2589320C2776694085 @default.
- W2589320 hasConceptScore W2589320C2776755627 @default.
- W2589320 hasConceptScore W2589320C2778461978 @default.
- W2589320 hasConceptScore W2589320C2779429289 @default.
- W2589320 hasConceptScore W2589320C2780007613 @default.
- W2589320 hasConceptScore W2589320C2781107101 @default.
- W2589320 hasConceptScore W2589320C2909962599 @default.
- W2589320 hasConceptScore W2589320C71924100 @default.
- W2589320 hasConceptScore W2589320C98274493 @default.
- W2589320 hasIssue "1" @default.
- W2589320 hasLocation W25893201 @default.
- W2589320 hasOpenAccess W2589320 @default.
- W2589320 hasPrimaryLocation W25893201 @default.
- W2589320 hasRelatedWork W2035891541 @default.
- W2589320 hasRelatedWork W2172055640 @default.
- W2589320 hasRelatedWork W2414699341 @default.
- W2589320 hasRelatedWork W2415370280 @default.
- W2589320 hasRelatedWork W2416971001 @default.
- W2589320 hasRelatedWork W2424848057 @default.
- W2589320 hasRelatedWork W2431556937 @default.